Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Scopus Biopharma Inc SCPS

Healthcare Biotechnology
Scopus BioPharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of its immuno-oncology programs. The Company’s Duet Platform relies on an immuno-oncology with a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) within the tumor microenvironment, while alleviating tumor immunosuppression to jump-start T cell... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:SCPS)

Scopus BioPharma's Subsidiary - Duet BioTherapeutics - Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswire November 7, 2023

Scopus BioPharma's Subsidiary - Duet BioTherapeutics - to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer

GlobeNewswire November 2, 2023

Scopus BioPharma's Subsidiary - Duet BioTherapeutics - Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer

GlobeNewswire November 10, 2022

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value

GlobeNewswire October 18, 2022

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

GlobeNewswire May 5, 2022

Scopus BioPharma's Subsidiary - Duet BioTherapeutics - to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit

GlobeNewswire March 22, 2022

Scopus BioPharma Provides Update Following Annual Meeting of Stockholders

GlobeNewswire January 10, 2022

DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS

PR Newswire January 6, 2022

Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster's Campaign Against the Company

GlobeNewswire December 17, 2021
View More News ››

Opinion & Analysis (GREY:SCPS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:SCPS)

SCPS ...... Targets are 42 & 49

Cheers !
Iseneschal - December 15, 2022

SCPS ....every dog has its day ; )

Heads up Early a.m runner ...then retracement....now big bounce
Iseneschal - December 15, 2022

SCPS ..... cut this one last week

Reason...... Directors in-fighting Let them sort it out  Too many others to put my money towards  Sorry bout dat !
Iseneschal - November 8, 2021

SCPS .... Hate to bash my own deal but.....

That 4K bid was smoke & mirrors.... LMFAO I really have my doubts about Level II depth....it's all BS !! Tread carefully my...
Iseneschal - November 4, 2021

SCPS ..... still here $3.60

not leaving
Iseneschal - November 3, 2021

SCPS .....nothin but roses

https://www.youtube.com/watch?v=aGyiuFZ7cs8
Iseneschal - October 25, 2021
View more Bullboard ››

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc. is a Canada-based junior exploration company. The Company is engaged in the exploration and ...
View More »